Ear nerve (auricular) stimulation to reduce blood loss during dialysis AV graft placement
Official title: Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Run by University Surgical Vascular · NCT06647017 · Data updated 2026-11-12
This trial will try a noninvasive ear (auricular) vagus nerve stimulation device to see if it reduces blood loss in adults having dialysis AV graft placement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University Surgical Vascular Industry-sponsored |
| Locations | 1 site (Watkinsville, Georgia) |
| Status | Recruiting |
| Started | November 13, 2024 |
| Main results expected | November 15, 2026 |
| Study ends | November 15, 2026 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT06647017 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 who are English proficient, able to give informed consent, and scheduled for dialysis AV graft (synthetic) placement are ideal candidates.
✕Probably not a fit
Patients with BMI ≥40, on platelet inhibitor medications, with a history of seizures or neurological disease, implanted electronic devices (e.g., pacemaker), abnormal ear anatomy or ear infection, pregnant or lactating people, or other significant comorbidities are unlikely to receive benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, sham-controlled, single-center pilot trial enrolls adults undergoing dialysis AV graft placement with a synthetic graft. Participants are randomized 1:1 to receive either 30 minutes of active transcutaneous auricular neurostimulation (tAN) or a sham device immediately before the procedure, in addition to standard surgical care. Blood loss volume and blood-based markers are measured before and during the operation to compare the two groups. The trial aims to determine whether preoperative tAN can lower intraoperative bleeding and related laboratory changes.
Why it matters
Potential benefit: If successful, the device could reduce intraoperative blood loss during AV graft placement, potentially lowering the need for transfusion and reducing surgical complications.
How similar studies have gone: Vagus nerve and transcutaneous auricular stimulation have shown effects in pain, inflammation, and other conditions, but applying tAN specifically to reduce surgical blood loss is novel with only limited preliminary support.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant is undergoing a dialysis port placement procedure using synthetic graft * Participant is between 18 and 75 years of age * Participant is English proficient * Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements Exclusion Criteria: * Participant has a BMI ≥ 40 * Participant is currently taking a platelet inhibitor medication * Participant has a history of epileptic seizures * Participant has a history of neurological diseases or traumatic brain injury * Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators * Participant has abnormal ear anatomy or ear infection present * Person of childbearing age, not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study * Person who is pregnant or lactating * Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
Where it's running
-
University Surgical Vascular
Watkinsville, Georgia, United States Recruiting
Study contacts
- Study coordinator: David Sailors, MD
- Email: dsailors@gasurgery.com
- Phone: (706) 549-8306
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Opioid-Free Anesthesia in FESS with ERAS
This study tries a opioid-free anesthesia approach during functional endoscopic sinus surgery to see if pain, nausea, and recovery are improved for adults undergoing this procedure.
-
Carbetocin Alone vs Carbetocin Plus Oxytocin After Elective Cesarean Delivery
This study tests whether giving carbetocin by itself after an elective cesarean is just as good as adding a supplemental oxytocin infusion.
-
Reltodecacog alfa plus usual care in adults needing urgent surgery while on a FXa DOAC
Aims to see if reltodecacog alfa can help blood clot faster during urgent surgery in adults taking FXa DOACs, compared with the usual care.
-
One IV dose of calcium gluconate given before cesarean to reduce bleeding in people at high risk for uterine atony
This will try a single IV dose of calcium gluconate given around cesarean delivery to see if it reduces blood loss for pregnant people at high risk of uterine atony.
-
Using nebulized tranexamic acid to reduce blood loss in sinus surgery
This study tests if giving a medication called tranexamic acid before sinus surgery can help reduce bleeding and improve the surgery for patients.
-
Improving blood management for patients undergoing heart surgery
This study is testing if giving patients iron before heart surgery can help them recover better and need fewer blood transfusions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.